UPDATED Apr 22, 2024
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
AZN | UK£112.50 | 3.4% | -8.5% | UK£174.4b | UK£130.75 | PE36.2x | E16.3% | 2.0% | ||
GSK | UK£16.40 | 1.8% | 9.3% | UK£67.0b | UK£20.06 | PE13.6x | E9.3% | 3.5% |